High dose ara-c
WebCYTARABINE (ARA-C) HIGH DOSE INDICATION Consolidation chemotherapy for AML in remission. Consider dose reduction to 1.5g/m2 for patient ≥60 years old and for patient … WebAn understanding of the cellular pharmacology, cytokinetics and pharmacokinetics of ara-C in leukemic mice showed substantial schedule-dependency. Exposure to high doses for a short duration (C × t) resulted in a palliative therapeutic outcome. In marked contrast, exposure to lower doses for a protracted period (c × T) was curative.
High dose ara-c
Did you know?
Web11 de abr. de 2024 · Currently, high doses of cytarabine arabinoside (Ara-C)-based combined chemotherapy are commonly used in acute myeloid leukemia (AML) therapy, but severe adverse effects and poor suppression effects in leukemia cells limit the clinical therapeutic efficiency of Ara-C-based chemotherapy due to a lack of targeting selectivity. … WebTreatment Name: HiDAC (High Dose Ara-C) HiDAC (High Dose Ara-C) is a Chemotherapy Regimen for Acute Myeloid Leukemia (AML) How does Hidac chemotherapy work? High …
WebIt is a combination of symptoms including a high temperature, aching muscles, bone pain, occasionally chest pain, a rash, sore eyes, and extreme weakness.Steroids can help to …
WebHigh-dose cytarabine (HD araC) therapy resulted from a theoretical model developed in the 1970s that attempted to maximize the anti-leukemia effect of cytarabine. Since that time, … Web30 de nov. de 2024 · Ara-C remains one of the most effective drugs used in the treatment of acute leukemia and other hematopoietic malignancies. In particular, high-dose ara-C is used during remission induction or as consolidation therapy after complete remission of acute myeloid leukemia in adults. Ara-C has also been used as an antiviral agent, …
Web13 de nov. de 2024 · In the control arm A, patients receive an alternating R-CHOP/R-DHAP induction followed by myeloablative consolidation (either BEAM or THAM: TBI, high dose Ara-C and melphalan). In arm A+I Ibrutinib is added to the R-CHOP cycles (560 mg day 1-19) and applied as maintenance (continuous dosing) for 2 years.
Web21 de set. de 2005 · Intervention Model: Parallel Assignment. Masking: None (Open Label) Primary Purpose: Treatment. Official Title: Efficacy of 6x R-CHOP Followed by Myeloablative Radiochemotherapy and Autologous Stem Cell Transplantation vs. 3 x (R-CHOP/R-DHAP) Followed by a High Dose ARA-C Containing Myeloablative Regimen … grady louis mcmurtryWeb20 de nov. de 2024 · Alternatively, a higher dose of 3.0mg/kg daunorubicin and 75mg/kg Ara-C was used (high dose DA therapy). For some experiments, doxorubicin was … grady location w101Web16 de ago. de 2024 · ALL induction followed by Blinatumomab and high-dose Ara-C prior to HSCT: CR for 24 months post HSCT CR for 8 months post HSCT CR 5 months post HSCT: Li et al. 29-year-old male with B/myeloid CD19+ MPAL and SET-NUP14 fusion gene transcript: ALL induction followed by hybrid Consolidation (hyper-CVAD-B and hyper … grady mahoney rochesterWeb1 de jul. de 1991 · Additionally, by some as yet unknown mechanism, high concentrations of ara-U cause accumulation of leukemia cells in S-phase, the phase of the cell cycle wherein ara-C is maximally effective. This effect of ara-U may add to the cytokinetic effects initiated by rapid cytoreduction, which summate in the observed enhancement of the proliferative … grady luckey atlantaWebNotably, almost all of the patients included had previously received a median cumulative doxorubicin-equivalent dose ranging from 292.9 mg/m 2 to 315 mg/m 2, below the limit of 400–500 mg/m 2 conventionally considered the safety limit to prevent anthracycline-related cardiotoxicity, 34 even if several studies have shown a linear correlation between doses … chimp drinking poweradeWeb25 de ago. de 2024 · Cytarabine (Ara-C) in consolidation therapy played important role in preventing relapses for AML patients achieved complete remission, but the optimum … chimp dna and human dnaWebIn conclusion, high-dose Ara-C and BEAM with stem cell rescue in newly diagnosed MCL patients responsive to R-CHOP is a manageable treatment with respect to toxicity. This regimen leads to long-term, but probably not durable, remissions. U2 - 10.1111/j.1365-2141.2008.07498.x. DO - 10.1111/j.1365-2141.2008.07498.x. chimp diet in the wild